ELIMINATION OF VIRAL HEPATITIS: CURRENT STRATEGIES AND ISSUES

ELIMINATION OF VIRAL HEPATITIS: CURRENT STRATEGIES AND ISSUES

The article considers modern approaches to the elimination of viral hepatitis B and C in the world, taking into account the guidelines developed by the World Health Organization. The current state and problematic aspects of the diagnosis and treatment of viral hepatitis with modern antiviral drugs a...

Full description

Bibliographic Details
Main Author:	Matsiyeuskaya N. V.
Format:	Article
Language:	Belarusian
Published:	Grodno State Medical University 2019-12-01
Series:	Žurnal Grodnenskogo Gosudarstvennogo Medicinskogo Universiteta
Subjects:	hcv hbv diagnosis elimination direct antiviral drugs vaccine prophylaxis treatment
Online Access:	http://journal-grsmu.by/index.php/ojs/article/view/2473

Similar Items

Towards the elimination of viral hepatitis in Thailand by the year 2030
by: Nawarat Posuwan, et al.
Published: (2020-09-01)

Comparison of the Mechanisms of Drug Resistance among HIV, Hepatitis B, and Hepatitis C
by: Robert W. Shafer, et al.
Published: (2010-12-01)

Hepatitis B virus reactivation sustained by a hepatitis B virus surface antigen immune-escape mutant isolate in a patient who was hepatitis B core antibody positive during treatment with sofosbuvir and velpatasvir for hepatitis C virus infection: a case report
by: Luca Foroghi Biland, et al.
Published: (2019-09-01)

Synthesis of some benzimidazole derivatives endowed with 1,2,3-triazole as potential inhibitors of hepatitis C virus
by: Youssif Bahaa G. M., et al.
Published: (2016-06-01)

Current international guidelines for the management of patients with chronic viral hepatitis C
by: Ju. L. Tonkikh, et al.
Published: (2020-10-01)

French hepatitis C care cascade: substantial impact of direct-acting antivirals, but the road to elimination is still long
by: Cécile Brouard, et al.
Published: (2020-10-01)

Viral Hepatitis in Renal Transplant Patients
by: Bernieh Bassam, et al.
Published: (1999-01-01)

Model of Care for Microelimination of Hepatitis C Virus Infection among People Who Inject Drugs
by: Francesco Giuseppe Foschi, et al.
Published: (2021-09-01)

Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district
by: Polilli E, et al.
Published: (2016-09-01)

Angiogenic output in viral hepatitis, C and B, and HCV-associated hepatocellular carcinoma
by: Mohamed A. Abdel Mohsen, et al.
Published: (2014-09-01)

A Global View to HBV Chronic Infection: Evolving Strategies for Diagnosis, Treatment and Prevention in Immunocompetent Individuals
by: Laura Ambra Nicolini, et al.
Published: (2019-09-01)

Sofosbuvir–daclatasvir improves hepatitis C virus–induced mixed cryoglobulinemia: Upper Egypt experience
by: Hassan AM, et al.
Published: (2018-06-01)

The influence of occult infection with hepatitis B virus on liver histology and response to interferon treatment in chronic hepatitis C patients
by: Claudia da Silva, et al.

Genetic Diversity and Selective Pressure in Hepatitis C Virus Genotypes 1–6: Significance for Direct-Acting Antiviral Treatment and Drug Resistance
by: Lize Cuypers, et al.
Published: (2015-09-01)

Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection
by: Keeffe Emmet B, et al.
Published: (2005-09-01)

OCCULT HEPATITIS B VIRUS INFECTION AND ASSOCIATED GENOTYPES AMONG HBSAG-NEGATIVE SUBJECTS IN BURKINA FASO
by: Birama DIARRA, et al.
Published: (2018-01-01)

Seroprevalence of hepatitis B, C and D viral among hemodialysis patients in Tehran
by: Davood Yadegarynia, et al.
Published: (2017-10-01)

Association of viral hepatitis and bipolar disorder: a nationwide population-based study
by: Lee-Won Chong, et al.
Published: (2018-06-01)

The evolving role of interferons in viral eradication strategies
by: Tomas Doyle
Published: (2016-04-01)

Postexposition prophylaxis for hepatotropic viruses (HBV and HCV) and human immunodeficiency virus (HIV)
by: Latković Marina B.
Published: (2010-01-01)

An update on the prevalence of viral hepatitis B and C among patients attending at tertiary hospital in South India
by: Aleem Ahmed Khan
Published: (2018-01-01)

Hepatitis C core antigen: a simple predictive marker for treatment response to the new direct-acting antiviral drugs in chronic HCV Egyptian patients
by: Asmaa M. Elbrolosy, et al.
Published: (2021-03-01)

Hepatitis C prevalence and risk factors in Georgia, 2015: setting a baseline for elimination
by: Liesl M. Hagan, et al.
Published: (2019-05-01)

Treatment outcomes of patients with chronic hepatitis C receiving sofosbuvir-based combination therapy within national hepatitis C elimination program in the country of Georgia
by: Tengiz Tsertsvadze, et al.
Published: (2020-01-01)

Editorial: Viral Hepatitis: Pathophysiology, Prevention, and Control
by: Cheng Kao, et al.
Published: (2021-08-01)

Impact of Sustained Viral Response in the Evolution of Minimal Hepatic Encephalopathy: a Prospective Pilot Study
by: Marta Hernández-Conde, et al.
Published: (2019-01-01)

Impact of sustained viral response in the evolution of minimal hepatic encephalopathy: A prospective pilot study
by: Marta Hernández-Conde, et al.
Published: (2019-05-01)

Seroprevalence for Hepatitis E and Other Viral Hepatitides among Diverse Populations, Malawi
by: Taha E. Taha, et al.
Published: (2015-07-01)

Independent Predictors of Mortality and Resource Utilization in Viral Hepatitis Related Hepatocellular Carcinoma
by: Pegah Golabi, et al.
Published: (2017-07-01)

Hepatitis G Virus Infection in Patients with Hepatitis C
by: Heba S. Selim, et al.
Published: (2010-09-01)

Hepatitis B And Hepatitis C Viral Infections And Associated Factors Among Patients With Diabetes Visiting Gondar Referral Teaching Hospital, Northwest Ethiopia: A Comparative Cross-Sectional Study
by: Million Y, et al.
Published: (2019-10-01)

Ultrasonic assessment of liver stiffness and carotid artery elasticity in patients with chronic viral hepatitis
by: Jing-Hua Li, et al.
Published: (2018-12-01)

Cytokines: their pathogenic and therapeutic role in chronic viral hepatitis Citoquinas: papel patogénico y terapéutico de las hepatitis crónicas víricas
by: J. R. Larrubia, et al.
Published: (2009-05-01)

The Risk of HBV, HCV and HIV Infections As a Result of Occupational Exposure Among Health Care Professionals and Postexposure Prophylaxis
by: Hürrem BODUR, et al.
Published: (2002-03-01)

Estimating the Transmission Risks of Viral Hepatitis and HIV Among Blood Donors in Hossana, Southern Ethiopia
by: Beykaso G, et al.
Published: (2021-07-01)

Prevalence of hepatitis C and B infection and HC V genotypes among hemodialysis patients in Khuzestan province, Southwest Iran
by: Assarehzadegan Mohammad, et al.
Published: (2009-01-01)

RELATIVE FREQUENCY OF HEPATITIS B VIRUS AND HEPATITIS C VIRUS INFECTIONS IN PATIENTS OF LIVER CIRRHOSIS IN CHILDREN
by: Syed Nizam Hussain Shah, et al.
Published: (2020-02-01)

Seroprevalence of Hepatitis B, Hepatitis C and Human Immunodeficiency viruses amongst Injecting Drug Users in Mumbai, India
by: Avantika Shukla, et al.
Published: (2014-06-01)

Investigation of the Seroprevalence of Viral Hepatitis and Syphilis Coinfection in HIV Positive Cases
by: Mehmet ÇABALAK, et al.
Published: (2020-09-01)

The need for a European hepatitis C programme monitoring resistance to direct-acting antiviral agents in real life to eliminate hepatitis C
by: Stephanie Popping, et al.
Published: (2018-07-01)